J.-H. Wang

531 total citations
13 papers, 403 citations indexed

About

J.-H. Wang is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.-H. Wang has authored 13 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.-H. Wang's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). J.-H. Wang is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). J.-H. Wang collaborates with scholars based in Taiwan, United States and China. J.-H. Wang's co-authors include C.-M. Lee, Chien‐Hui Hung, Chia‐Hsiang Chen, Tsung‐Hui Hu, Sheng‐Nan Lu, Yi‐Hao Yen, Po‐Lin Tseng, C.‐S. Changchien, Hung‐Da Tung and Ming‐Chao Tsai and has published in prestigious journals such as The American Journal of Gastroenterology, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

J.-H. Wang

12 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-H. Wang Taiwan	10	366	364	32	25	16	13	403
C.-M. Lee Taiwan	10	365 1.0×	364 1.0×	30 0.9×	25 1.0×	16 1.0×	13	407
Waleed Al–Hamoudi Saudi Arabia	14	322 0.9×	362 1.0×	26 0.8×	21 0.8×	12 0.8×	29	424
Chao‐Hung Hung Taiwan	13	534 1.5×	542 1.5×	19 0.6×	31 1.2×	17 1.1×	18	585
Huanwei Zheng China	8	204 0.6×	214 0.6×	31 1.0×	30 1.2×	13 0.8×	31	299
Rob Myers France	9	311 0.8×	327 0.9×	23 0.7×	18 0.7×	11 0.7×	20	363
S. Lobello Italy	8	572 1.6×	579 1.6×	26 0.8×	20 0.8×	11 0.7×	16	630
G. Fattovich Italy	3	368 1.0×	349 1.0×	14 0.4×	12 0.5×	9 0.6×	6	391
Hironori Tanimoto Japan	7	350 1.0×	307 0.8×	27 0.8×	26 1.0×	3 0.2×	18	388
Caterina Furlan Italy	10	264 0.7×	270 0.7×	21 0.7×	23 0.9×	3 0.2×	18	325
Anika Wranke Germany	12	398 1.1×	387 1.1×	16 0.5×	26 1.0×	5 0.3×	20	443

Countries citing papers authored by J.-H. Wang

Since Specialization

Citations

This map shows the geographic impact of J.-H. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-H. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-H. Wang more than expected).

Fields of papers citing papers by J.-H. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-H. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-H. Wang. The network helps show where J.-H. Wang may publish in the future.

Co-authorship network of co-authors of J.-H. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of J.-H. Wang. A scholar is included among the top collaborators of J.-H. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-H. Wang. J.-H. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jeng, Wen‐Juei, Tsung‐Hui Hu, J.-H. Wang, et al.. (2025). Higher Relapse Rate in HBeAg-Negative Patients After Cessation of Tenofovir Alafenamide Compared With Entecavir or Tenofovir Disoproxil Fumarate. The American Journal of Gastroenterology. 120(11). 2567–2575. 1 indexed citations

Chen, Chia‐Hsiang, et al.. (2017). Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients. Clinical Microbiology and Infection. 24(9). 997–1003. 48 indexed citations

Wang, J.-H., et al.. (2017). Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study. Clinical Microbiology and Infection. 23(7). 464–469. 31 indexed citations

Tsai, Ming‐Chao, Chia‐Hsiang Chen, Po‐Lin Tseng, et al.. (2015). Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience. Clinical Microbiology and Infection. 22(1). 95.e1–95.e7. 50 indexed citations

Lee, C.-M., Tsung‐Hui Hu, J.-H. Wang, et al.. (2013). Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants. Journal of Antimicrobial Chemotherapy. 68(9). 2154–2163. 33 indexed citations

Tsai, Ming‐Chao, Chia‐Hsiang Chen, Chien‐Hui Hung, et al.. (2013). A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study. Clinical Microbiology and Infection. 20(2). O90–O100. 25 indexed citations

Hsieh, Yao‐Ching, et al.. (2013). Factors related to postoperative pain among patients who underwent radiofrequency ablation of hepatocellular carcinoma. Clinical Radiology. 68(6). 600–607. 3 indexed citations

Hung, Chien‐Hui, J.-H. Wang, C.-M. Lee, et al.. (2012). A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy. Journal of Antimicrobial Chemotherapy. 67(11). 2766–2772. 71 indexed citations

Sheng, Junqing, et al.. (2012). Symptomatic diffuse esophageal spasm as a major ictal manifestation of post-traumatic epilepsy: a case report. Diseases of the Esophagus. 26(3). 327–330. 4 indexed citations

10.

Tsai, Ming‐Chao, C.-M. Lee, King‐Wah Chiu, et al.. (2011). A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice. Journal of Antimicrobial Chemotherapy. 67(3). 696–699. 25 indexed citations

11.

Yen, Yi‐Hao, C.‐S. Changchien, J.-H. Wang, et al.. (2009). A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients. Digestive and Liver Disease. 41(6). 431–441. 31 indexed citations

12.

Lee, C.-M., Chia‐Hsiang Chen, Sheng‐Nan Lu, et al.. (2003). Prevalence and Clinical Implications of Hepatitis B Virus Genotypes in Southern Taiwan. Scandinavian Journal of Gastroenterology. 38(1). 95–101. 60 indexed citations

13.

Hung, Chien‐Hui, C.‐S. Changchien, Sheng‐Nan Lu, et al.. (2001). Sonographic features of hepatic adenomas with pathologic correlation. Abdominal Imaging. 26(5). 500–506. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact